$KIDS

Squadron Capital LLC sold $943K of KIDS

Squadron Capital LLC sold 38,300 shares of ORTHOPEDIATRICS CORP (KIDS) at an average of $24.63 ($24.28–$25.75, $0.94M total) across 3 trades over 2026-08-24 to 2026-08-26. Filed jointly with Squadron Capital Holdings LLC (10% owner).

Original reporting
SEC EDGAR · Squadron Capital LLC, Squadron Capital Holdings LLC
Published Aug 26, 2026, 10:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KIDS
Bearish
medium confidence
Mentioned
$KIDS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSBearishLow
01

Why it matters

The transaction modestly reduces insider ownership, which may be interpreted as a slight bearish cue.

02

Market read

A small insider sale with limited price impact; relevant for short‑term traders monitoring insider activity.

03

What to watch

Squadron Capital may be reallocating capital across its portfolio; the sale does not reflect company fundamentals.

Relevance 5/10Novelty 4/10Timing: same-day filing on 2026-08-26

Background

Form 4 filings disclose insider transactions; this filing reports a sale by a 10% owner.

Company-level read

Ticker impact

$KIDSBearishMedium confidence
Context

Squadron Capital LLC sold 38,300 shares of Orthopedics Corp (KIDS) for $943,302 in a Form 4 filing.

Expected impact

Modest downward pressure on KIDS price in the short term.

Evidence & confidence

A 10% owner sold ~0.5% of its holdings; size is modest but may influence sentiment.

Market effects

Minor impact on the medical device sector; insider sales are common and unlikely to shift sector sentiment.

No significant regional effect.

Limited to investors tracking KIDS.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Orthopedics Corp

    Medical device manufacturer listed as KIDS.

  • Squadron Capital LLC

    10% shareholder of Orthopedics Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.